NCT03790787View on ClinicalTrials.gov

Drug Interaction Study Between Dorzagliatin and Empagliflozin

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 18, 2019

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Patients
Interventions
DRUG

Empagliflozin

Empagliflozin as Jardiance® 25 mg film-coated tablets for oral administration

DRUG

Dorzagliatin

Glucokinase activator currently under development

Trial Locations (1)

07601

Frontage Clinical Services Inc., Hackensack

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT03790787 - Drug Interaction Study Between Dorzagliatin and Empagliflozin | Biotech Hunter | Biotech Hunter